The London Psychiatry Centre: World First: New Model And Treatment For Mood Disorders Has Very High Success Rate
LONDON, Oct. 20, 2022 /PRNewswire/ -- A world's first model for mood disorders involving precision medicine and mitochondrial treatment with High Dose Levothyroxine and rTMS (patent application